Pieris Pharma (PIRS) Tops Q3 EPS by 1c

November 10, 2016 7:17 AM EST

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Pieris Pharma (NASDAQ: PIRS) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15).

Cash and cash equivalents totalled $36.6 million at September 30, 2016, compared to $29.3 million at December 31, 2015. The increase in cash was driven primarily by the $16.5 million gross private placement financing completed in June 2016.

For earnings history and earnings-related data on Pieris Pharma (PIRS) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment